{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,2,27]],"date-time":"2025-02-27T05:24:15Z","timestamp":1740633855804,"version":"3.38.0"},"reference-count":39,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,2,26]],"date-time":"2025-02-26T00:00:00Z","timestamp":1740528000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2025,2,26]],"date-time":"2025-02-26T00:00:00Z","timestamp":1740528000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/100013276","name":"Interreg","doi-asserted-by":"publisher","award":["EAPA_791\/2018"],"award-info":[{"award-number":["EAPA_791\/2018"]}],"id":[{"id":"10.13039\/100013276","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["EJNMMI Res"],"abstract":"<jats:title>Abstract<\/jats:title>\n          <jats:sec>\n            <jats:title>Background<\/jats:title>\n            <jats:p>Niemann\u2013Pick disease type C (NP-C) is a rare genetic lysosomal lipid storage disorder characterized by progressive neurological impairment. Early diagnosis is critical for initiating treatment with miglustat, which can decelerate disease progression. In this study, we evaluated a cohort of 22 NP-C patients who underwent MRI, [<jats:sup>18<\/jats:sup>F]FDG PET, and clinical assessment at baseline. We performed a cross-sectional and longitudinal imaging study evaluating the role of [<jats:sup>18<\/jats:sup>F]FDG PET as an adjunct diagnostic tool for NP-C alongside MRI, the current neuroimaging standard.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Results<\/jats:title>\n            <jats:p>Group-level MRI analysis identified significant cerebellar and thalamic atrophy (d\u2009=\u20091.56, <jats:italic>p<\/jats:italic>\u2009&lt;\u20090.0001 and d\u2009=\u20091.09, <jats:italic>p<\/jats:italic>\u2009&lt;\u20090.001, respectively), with less pronounced involvement of the frontal lobe and hippocampus, which aligned with existing neuropathological understanding and guidelines. Conversely, [<jats:sup>18<\/jats:sup>F]FDG PET imaging revealed extensive hypometabolism in the cerebellum, thalamus, and cingulate cortex (d\u2009=\u20091.42, <jats:italic>p<\/jats:italic>\u2009&lt;\u20090.0001), and moderate hypometabolism in broad frontotemporal areas. [<jats:sup>18<\/jats:sup>F]FDG PET provided higher effect sizes across all brain regions, including regions without apparent atrophy, which suggests that it may be more sensitive than MRI for detecting NP-C neurodegenerative changes. Single-subject visual assessment of individual PET images further validated the clinical utility of [<jats:sup>18<\/jats:sup>F]FDG PET, with significant hypometabolism observed in the cerebellum, thalamus and anterior and posterior cingulate reported by physicians in 17\/22 patients. Both hypometabolism and atrophy in the cerebellum were associated with ataxia, (more strongly indicated by [<jats:sup>18<\/jats:sup>F]FDG PET, <jats:italic>p<\/jats:italic>\u2009&lt;\u20090.0001 vs. MRI, <jats:italic>p<\/jats:italic>\u2009=\u20090.07). Medial temporal lobe atrophy was associated with cognitive impairment (<jats:italic>p<\/jats:italic>\u2009&lt;\u20090.05), and frontal hypometabolism was slightly related to behavioural impairment (<jats:italic>p<\/jats:italic>\u2009&lt;\u20090.07). Longitudinal [<jats:sup>18<\/jats:sup>F]FDG PET analysis revealed progressive subcortical, cortical and cerebellar hypometabolism, which was most pronounced in the cerebellum (-12% per year, <jats:italic>p<\/jats:italic>\u2009&lt;\u20090.001). Patients treated with miglustat showed a trend towards attenuated cerebellar hypometabolism progression compared to untreated patients (<jats:italic>p<\/jats:italic>\u2009=\u20090.10).<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Conclusions<\/jats:title>\n            <jats:p>Our findings delineate a discernible hypometabolism pattern specific to NP-C that distinguishes it from other neurodegenerative conditions, thus suggesting that [<jats:sup>18<\/jats:sup>F]FDG PET might be a promising tool for NP-C diagnosis and to study disease progression.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Trial registration<\/jats:title>\n            <jats:p>XUNTA 2015\/140. Registered 21 April 2015.<\/jats:p>\n          <\/jats:sec>","DOI":"10.1186\/s13550-025-01208-8","type":"journal-article","created":{"date-parts":[[2025,2,26]],"date-time":"2025-02-26T14:10:15Z","timestamp":1740579015000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Hypometabolism and atrophy patterns associated with Niemann-Pick type C"],"prefix":"10.1186","volume":"15","author":[{"given":"Jes\u00fas","family":"Silva-Rodr\u00edguez","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Cristina","family":"Castro","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Julia","family":"Cort\u00e9s","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Manuel","family":"Arias","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Virginia","family":"Pubul","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Alexis","family":"Moscoso","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Michel J.","family":"Grothe","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gabriel","family":"Reynes-Llompart","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Laura","family":"Rodr\u00edguez-Bel","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jordi","family":"Gascon-Bayarri","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mar\u00eda Jes\u00fas","family":"Sobrido","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7322-2195","authenticated-orcid":false,"given":"Pablo","family":"Aguiar","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2025,2,26]]},"reference":[{"issue":"4","key":"1208_CR1","doi-asserted-by":"publisher","first-page":"269","DOI":"10.1034\/j.1399-0004.2003.00147.x","volume":"64","author":"MT Vanier","year":"2003","unstructured":"Vanier MT, Millat G. Niemann-Pick disease type C. Clin Genet. 2003;64(4):269\u201381.","journal-title":"Clin Genet"},{"issue":"16","key":"1208_CR2","doi-asserted-by":"publisher","first-page":"5886","DOI":"10.1073\/pnas.0308456101","volume":"101","author":"DE Sleat","year":"2004","unstructured":"Sleat DE, Wiseman JA, El-Banna M, Price SM, Verot L, Shen MM, et al. Genetic evidence for nonredundant functional cooperativity between NPC1 and NPC2 in lipid transport. Proc Natl Acad Sci U S A. 2004;101(16):5886\u201391.","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"1","key":"1208_CR3","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.jns.2006.05.054","volume":"249","author":"C Iturriaga","year":"2006","unstructured":"Iturriaga C, Pineda M, Fern\u00e1ndez-Valero EM, Vanier MT, Coll MJ. Niemann-Pick C disease in Spain: clinical spectrum and development of a disability scale. J Neurol Sci. 2006;249(1):1\u20136.","journal-title":"J Neurol Sci"},{"issue":"1\u20132","key":"1208_CR4","first-page":"152","volume":"98","author":"NP-C Guidelines Working","year":"2009","unstructured":"Guidelines Working NP-C, Group, Wraith JE, Baumgartner MR, Bembi B, Covanis A, Levade T, et al. Recommendations on the diagnosis and management of Niemann-Pick disease type C. Mol Genet Metab. 2009;98(1\u20132):152\u201365.","journal-title":"Mol Genet Metab"},{"issue":"1","key":"1208_CR5","doi-asserted-by":"publisher","first-page":"20","DOI":"10.1186\/s13023-018-0985-1","volume":"14","author":"MJ Sobrido","year":"2019","unstructured":"Sobrido MJ, Bauer P, de Koning T, Klopstock T, Nadjar Y, Patterson MC, et al. Recommendations for patient screening in ultra-rare inherited metabolic diseases: what have we learned from Niemann-Pick disease type C? Orphanet J Rare Dis. 2019;14(1):20.","journal-title":"Orphanet J Rare Dis"},{"issue":"5","key":"1208_CR6","doi-asserted-by":"publisher","first-page":"420","DOI":"10.1136\/practneurol-2019-002236","volume":"19","author":"M Lad","year":"2019","unstructured":"Lad M, Thomas RH, Anderson K, Griffiths TD. Niemann-Pick type C: contemporary diagnosis and treatment of a classical disorder. Pract Neurol. 2019;19(5):420\u20133.","journal-title":"Pract Neurol"},{"issue":"1","key":"1208_CR7","doi-asserted-by":"publisher","first-page":"32","DOI":"10.1186\/s13023-019-0996-6","volume":"14","author":"M Pineda","year":"2019","unstructured":"Pineda M, Jur\u00ed\u010dkov\u00e1 K, Karimzadeh P, Kolnikova M, Malinova V, Insua JL, et al. Disease characteristics, prognosis and miglustat treatment effects on disease progression in patients with Niemann-Pick disease type C: an international, multicenter, retrospective chart review. Orphanet J Rare Dis. 2019;14(1):32.","journal-title":"Orphanet J Rare Dis"},{"issue":"6","key":"1208_CR8","first-page":"1412","volume":"144","author":"DE Brown","year":"1994","unstructured":"Brown DE, Thrall MA, Walkley SU, Wenger DA, Mitchell TW, Smith MO, et al. Feline Niemann-Pick disease type C. Am J Pathol. 1994;144(6):1412\u20135.","journal-title":"Am J Pathol"},{"issue":"2","key":"1208_CR9","doi-asserted-by":"publisher","first-page":"218","DOI":"10.1007\/s002210100870","volume":"141","author":"WY Ong","year":"2001","unstructured":"Ong WY, Kumar U, Switzer RC, Sidhu A, Suresh G, Hu CY, et al. Neurodegeneration in Niemann-Pick type C disease mice. Exp Brain Res. 2001;141(2):218\u201331.","journal-title":"Exp Brain Res"},{"issue":"7","key":"1208_CR10","doi-asserted-by":"publisher","first-page":"1334","DOI":"10.3174\/ajnr.A3356","volume":"34","author":"M Walterfang","year":"2013","unstructured":"Walterfang M, Patenaude B, Abel LA, Kluenemann H, Bowman EA, Fahey MC, et al. Subcortical volumetric reductions in adult Niemann-Pick disease type C: a cross-sectional study. AJNR Am J Neuroradiol. 2013;34(7):1334\u201340.","journal-title":"AJNR Am J Neuroradiol"},{"issue":"1","key":"1208_CR11","doi-asserted-by":"publisher","first-page":"85","DOI":"10.1016\/j.ymgme.2012.11.009","volume":"108","author":"M Walterfang","year":"2013","unstructured":"Walterfang M, Abel LA, Desmond P, Fahey MC, Bowman EA, Velakoulis D. Cerebellar volume correlates with saccadic gain and ataxia in adult Niemann-Pick type C. Mol Genet Metab. 2013;108(1):85\u20139.","journal-title":"Mol Genet Metab"},{"issue":"3","key":"1208_CR12","doi-asserted-by":"publisher","first-page":"462","DOI":"10.1111\/j.1468-1331.2011.03545.x","volume":"19","author":"M Walterfang","year":"2012","unstructured":"Walterfang M, Macfarlane MD, Looi JCL, Abel L, Bowman E, Fahey MC, et al. Pontine-to-midbrain ratio indexes ocular-motor function and illness stage in adult Niemann-Pick disease type C. Eur J Neurol. 2012;19(3):462\u20137.","journal-title":"Eur J Neurol"},{"issue":"7","key":"1208_CR13","doi-asserted-by":"publisher","first-page":"1340","DOI":"10.3174\/ajnr.A2490","volume":"32","author":"M Walterfang","year":"2011","unstructured":"Walterfang M, Fahey M, Abel L, Fietz M, Wood A, Bowman E, et al. Size and shape of the corpus callosum in adult Niemann-Pick type C reflects state and trait illness variables. AJNR Am J Neuroradiol. 2011;32(7):1340\u20136.","journal-title":"AJNR Am J Neuroradiol"},{"issue":"1","key":"1208_CR14","doi-asserted-by":"publisher","first-page":"49","DOI":"10.1212\/WNL.0b013e3181e6210e","volume":"75","author":"M Walterfang","year":"2010","unstructured":"Walterfang M, Fahey M, Desmond P, Wood A, Seal ML, Steward C, et al. White and Gray matter alterations in adults with Niemann-Pick disease type C: a cross-sectional study. Neurology. 2010;75(1):49\u201356.","journal-title":"Neurology"},{"key":"1208_CR15","doi-asserted-by":"crossref","unstructured":"Masingue M, Adanyeguh I, Nadjar Y, Sedel F, Galanaud D, Mochel F. Evolution of structural neuroimaging biomarkers in a series of adult patients with Niemann-Pick type C under treatment. Orphanet J Rare Dis [Internet]. 2017 Feb 2 [cited 2020 May 19];12. Available from: https:\/\/www.ncbi.nlm.nih.gov\/pmc\/articles\/PMC5289046\/","DOI":"10.1186\/s13023-017-0579-3"},{"issue":"5","key":"1208_CR16","doi-asserted-by":"publisher","first-page":"325","DOI":"10.1016\/j.pediatrneurol.2005.05.004","volume":"33","author":"TP Trouard","year":"2005","unstructured":"Trouard TP, Heidenreich RA, Seeger JF, Erickson RP. Diffusion tensor imaging in Niemann-Pick type C disease. Pediatr Neurol. 2005;33(5):325\u201330.","journal-title":"Pediatr Neurol"},{"issue":"3","key":"1208_CR17","doi-asserted-by":"publisher","first-page":"291","DOI":"10.1016\/j.ymgme.2009.10.180","volume":"99","author":"M Scheel","year":"2010","unstructured":"Scheel M, Abegg M, Lanyon LJ, Mattman A, Barton JJ. Eye movement and diffusion tensor imaging analysis of treatment effects in a Niemann-Pick type C patient. Mol Genet Metab. 2010;99(3):291\u20135.","journal-title":"Mol Genet Metab"},{"issue":"2","key":"1208_CR18","doi-asserted-by":"publisher","first-page":"426","DOI":"10.1093\/brain\/awy338","volume":"142","author":"Y You","year":"2019","unstructured":"You Y, Joseph C, Wang C, Gupta V, Liu S, Yiannikas C, et al. Demyelination precedes axonal loss in the transneuronal spread of human neurodegenerative disease. Brain. 2019;142(2):426\u201342.","journal-title":"Brain"},{"issue":"3","key":"1208_CR19","doi-asserted-by":"publisher","first-page":"330","DOI":"10.1016\/j.ymgme.2012.03.012","volume":"106","author":"MC Patterson","year":"2012","unstructured":"Patterson MC, Hendriksz CJ, Walterfang M, Sedel F, Vanier MT, Wijburg F, et al. Recommendations for the diagnosis and management of Niemann-Pick disease type C: an update. Mol Genet Metab. 2012;106(3):330\u201344.","journal-title":"Mol Genet Metab"},{"issue":"11","key":"1208_CR20","first-page":"1778","volume":"47","author":"L Mosconi","year":"2006","unstructured":"Mosconi L, Sorbi S, de Leon MJ, Li Y, Nacmias B, Myoung PS, et al. Hypometabolism exceeds atrophy in presymptomatic early-onset Familial Alzheimer\u2019s disease. J Nucl Med Off Publ Soc Nucl Med. 2006;47(11):1778\u201386.","journal-title":"J Nucl Med Off Publ Soc Nucl Med"},{"issue":"3","key":"1208_CR21","doi-asserted-by":"publisher","first-page":"241","DOI":"10.1016\/S1474-4422(18)30028-0","volume":"17","author":"BA Gordon","year":"2018","unstructured":"Gordon BA, Blazey TM, Su Y, Hari-Raj A, Dincer A, Flores S, et al. Spatial patterns of neuroimaging biomarker change in individuals from families with autosomal dominant Alzheimer\u2019s disease: a longitudinal study. Lancet Neurol. 2018;17(3):241\u201350.","journal-title":"Lancet Neurol"},{"issue":"9","key":"1208_CR22","doi-asserted-by":"publisher","first-page":"4076","DOI":"10.1172\/JCI69411","volume":"123","author":"CC Tang","year":"2013","unstructured":"Tang CC, Feigin A, Ma Y, Habeck C, Paulsen JS, Leenders KL, et al. Metabolic network as a progression biomarker of premanifest Huntington\u2019s disease. J Clin Invest. 2013;123(9):4076\u201388.","journal-title":"J Clin Invest"},{"key":"1208_CR23","doi-asserted-by":"publisher","first-page":"101594","DOI":"10.1016\/j.nicl.2018.11.004","volume":"21","author":"F Albrecht","year":"2019","unstructured":"Albrecht F, Ballarini T, Neumann J, Schroeter ML. FDG-PET hypometabolism is more sensitive than MRI atrophy in Parkinson\u2019s disease: A whole-brain multimodal imaging meta-analysis. NeuroImage Clin. 2019;21:101594.","journal-title":"NeuroImage Clin"},{"issue":"9","key":"1208_CR24","doi-asserted-by":"publisher","first-page":"1973","DOI":"10.1016\/j.neurobiolaging.2014.04.006","volume":"35","author":"V Kljajevic","year":"2014","unstructured":"Kljajevic V, Grothe MJ, Ewers M, Teipel S. Distinct pattern of hypometabolism and atrophy in preclinical and predementia Alzheimer\u2019s disease. Neurobiol Aging. 2014;35(9):1973\u201381.","journal-title":"Neurobiol Aging"},{"key":"1208_CR25","doi-asserted-by":"publisher","unstructured":"Lau TY, Kao YH, Toh HB, Sivaratnam D, Lichtenstein M, Velakoulis D et al. Brain hypometabolic changes in 14 adolescent\u2013adult patients with Niemann\u2013Pick disease type C assessed by 18F-fluorodeoxyglucose positron emission tomography. J Neurol [Internet]. 2021 Apr 8 [cited 2021 May 12]; Available from: http:\/\/link.springer.com\/https:\/\/doi.org\/10.1007\/s00415-021-10535-4","DOI":"10.1007\/s00415-021-10535-4"},{"issue":"1","key":"1208_CR26","doi-asserted-by":"publisher","first-page":"57","DOI":"10.1016\/j.pediatrneurol.2010.08.004","volume":"44","author":"A Kumar","year":"2011","unstructured":"Kumar A, Chugani HT. Niemann-Pick disease type C: unique 2-deoxy-2[18F] fluoro-D-glucose PET abnormality. Pediatr Neurol. 2011;44(1):57\u201360.","journal-title":"Pediatr Neurol"},{"issue":"8","key":"1208_CR27","doi-asserted-by":"publisher","first-page":"537","DOI":"10.1016\/S0929-6646(11)60080-6","volume":"110","author":"JY Huang","year":"2011","unstructured":"Huang JY, Peng SF, Yang CC, Yen KY, Tzen KY, Yen RF. Neuroimaging findings in a brain with Niemann-Pick type C disease. J Formos Med Assoc Taiwan Yi Zhi. 2011;110(8):537\u201342.","journal-title":"J Formos Med Assoc Taiwan Yi Zhi"},{"issue":"3","key":"1208_CR28","doi-asserted-by":"publisher","first-page":"642","DOI":"10.1007\/s00415-014-7619-x","volume":"262","author":"A Benussi","year":"2015","unstructured":"Benussi A, Alberici A, Premi E, Bertasi V, Cotelli MS, Turla M, et al. Phenotypic heterogeneity of Niemann-Pick disease type C in monozygotic twins. J Neurol. 2015;262(3):642\u20137.","journal-title":"J Neurol"},{"issue":"2","key":"1208_CR29","doi-asserted-by":"publisher","first-page":"791","DOI":"10.1016\/j.neuroimage.2011.10.025","volume":"62","author":"J Ashburner","year":"2012","unstructured":"Ashburner J. SPM: a history. NeuroImage. 2012;62(2):791\u2013800.","journal-title":"NeuroImage"},{"issue":"1","key":"1208_CR30","doi-asserted-by":"publisher","first-page":"192","DOI":"10.1002\/jmri.22003","volume":"31","author":"JV Manj\u00f3n","year":"2010","unstructured":"Manj\u00f3n JV, Coup\u00e9 P, Mart\u00ed-Bonmat\u00ed L, Collins DL, Robles M. Adaptive non-local means denoising of MR images with spatially varying noise levels. J Magn Reson Imaging JMRI. 2010;31(1):192\u2013203.","journal-title":"J Magn Reson Imaging JMRI"},{"issue":"3","key":"1208_CR31","doi-asserted-by":"publisher","first-page":"839","DOI":"10.1016\/j.neuroimage.2005.02.018","volume":"26","author":"J Ashburner","year":"2005","unstructured":"Ashburner J, Friston KJ. Unified segmentation. NeuroImage. 2005;26(3):839\u201351.","journal-title":"NeuroImage"},{"issue":"1","key":"1208_CR32","doi-asserted-by":"publisher","first-page":"95","DOI":"10.1016\/j.neuroimage.2007.07.007","volume":"38","author":"J Ashburner","year":"2007","unstructured":"Ashburner J. A fast diffeomorphic image registration algorithm. NeuroImage. 2007;38(1):95\u2013113.","journal-title":"NeuroImage"},{"issue":"2","key":"1208_CR33","doi-asserted-by":"publisher","first-page":"264","DOI":"10.1002\/mds.26854","volume":"32","author":"P Aguiar","year":"2017","unstructured":"Aguiar P, Pardo J, Arias M, Quint\u00e1ns B, Fern\u00e1ndez-Prieto M, Mart\u00ednez-Regueiro R, et al. PET and MRI detection of early and progressive neurodegeneration in spinocerebellar ataxia type 36. Mov Disord Off J Mov Disord Soc. 2017;32(2):264\u201373.","journal-title":"Mov Disord Off J Mov Disord Soc"},{"key":"1208_CR34","doi-asserted-by":"publisher","first-page":"117229","DOI":"10.1016\/j.neuroimage.2020.117229","volume":"222","author":"FJ L\u00f3pez-Gonz\u00e1lez","year":"2020","unstructured":"L\u00f3pez-Gonz\u00e1lez FJ, Silva-Rodr\u00edguez J, Paredes-Pacheco J, Ni\u00f1erola-Baiz\u00e1n A, Efthimiou N, Mart\u00edn-Mart\u00edn C, et al. Intensity normalization methods in brain FDG-PET quantification. NeuroImage. 2020;222:117229.","journal-title":"NeuroImage"},{"issue":"2","key":"1208_CR35","doi-asserted-by":"publisher","first-page":"632","DOI":"10.1007\/s00259-021-05603-w","volume":"49","author":"E Guedj","year":"2022","unstructured":"Guedj E, Varrone A, Boellaard R, Albert NL, Barthel H, Van Berckel B, et al. EANM procedure guidelines for brain PET imaging using [18F]FDG, version 3. Eur J Nucl Med Mol Imaging. 2022;49(2):632\u201351.","journal-title":"Eur J Nucl Med Mol Imaging"},{"issue":"4","key":"1208_CR36","doi-asserted-by":"publisher","first-page":"224","DOI":"10.1002\/hbm.10123","volume":"19","author":"A Hammers","year":"2003","unstructured":"Hammers A, Allom R, Koepp MJ, Free SL, Myers R, Lemieux L, et al. Three-dimensional maximum probability atlas of the human brain, with particular reference to the Temporal lobe. Hum Brain Mapp. 2003;19(4):224\u201347.","journal-title":"Hum Brain Mapp"},{"issue":"16","key":"1208_CR37","doi-asserted-by":"publisher","first-page":"e1702","DOI":"10.1212\/WNL.0000000000009290","volume":"94","author":"T Bremova-Ertl","year":"2020","unstructured":"Bremova-Ertl T, Sztatecsny C, Brendel M, Moser M, M\u00f6ller B, Clevert DA, et al. Clinical, ocular motor, and imaging profile of Niemann-Pick type C heterozygosity. Neurology. 2020;94(16):e1702\u201315.","journal-title":"Neurology"},{"issue":"4","key":"1208_CR38","doi-asserted-by":"publisher","first-page":"358","DOI":"10.1016\/j.ymgme.2009.11.007","volume":"99","author":"M Pineda","year":"2010","unstructured":"Pineda M, Perez-Poyato MS, O\u2019Callaghan M, Vilaseca MA, Pocovi M, Domingo R, et al. Clinical experience with miglustat therapy in pediatric patients with Niemann-Pick disease type C: a case series. Mol Genet Metab. 2010;99(4):358\u201366.","journal-title":"Mol Genet Metab"},{"issue":"9","key":"1208_CR39","doi-asserted-by":"publisher","first-page":"2106","DOI":"10.1007\/s00415-015-7819-z","volume":"262","author":"EA Bowman","year":"2015","unstructured":"Bowman EA, Walterfang M, Abel L, Desmond P, Fahey M, Velakoulis D. Longitudinal changes in cerebellar and subcortical volumes in adult-onset Niemann-Pick disease type C patients treated with miglustat. J Neurol. 2015;262(9):2106\u201314.","journal-title":"J Neurol"}],"container-title":["EJNMMI Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13550-025-01208-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s13550-025-01208-8\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13550-025-01208-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,2,26]],"date-time":"2025-02-26T14:10:19Z","timestamp":1740579019000},"score":1,"resource":{"primary":{"URL":"https:\/\/ejnmmires.springeropen.com\/articles\/10.1186\/s13550-025-01208-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,2,26]]},"references-count":39,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["1208"],"URL":"https:\/\/doi.org\/10.1186\/s13550-025-01208-8","relation":{},"ISSN":["2191-219X"],"issn-type":[{"value":"2191-219X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,2,26]]},"assertion":[{"value":"9 October 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"14 February 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"26 February 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"This study was approved by the Ethics Committee Xunta de Galicia (reference XUNTA 2015\/140), registered 21 April 2015 and complied with the declaration of Helsinki. Informed consent was obtained from all individual participants included in the study.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"This study was funded by Actelion Pharmaceuticals Ltd, makers of Zavesca (miglustat). JSR and PA are consultants for Qubiotech Health Intelligence SL. No other potential conflicts of interest relevant to this article exist.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"16"}}